The Role of Lung Ultrasound in The Diagnosis of Weaning -Induced Pulmonary Edema

July 8, 2020 updated by: Dina Ali Ahmed, Assiut University

The aim of the work is to

  1. Assess the incidence of weaning induced pulmonary adema(WIPO).
  2. Assess the risk factors of WIPO.
  3. Evaluate the role of lung ultrasound in detecting WIPO during spontenous breathing trial(SBT).
  4. Detect the threshold of B-line increase (Delta-B-lines) that provided the best diagnostic accuracy of WIPO.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

50

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 60 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study will include patients on mechanical ventilation who will be suitable for spontaneous breathing trial (SBT).

Description

Inclusion Criteria:

  • The study will include patients on mechanical ventilation who will be suitable for spontaneous breathing trial (SBT).

Exclusion Criteria:

  • Patients with poor lung ultrasound window, history of cardiomyopathy, significant valvular disease (aortic or mitral insufficiency of grade ≥ 2, mild or severe aortic and mitral stenosis) will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
group 1
patient who will develop weaning induced pulmonary adema
patient with or without weaning induced pulmonary adema
group 2
patient who will nor develop weaning induced pulmonary adema
patient with or without weaning induced pulmonary adema

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
the number of B-lines in lung ultrasound and its accuracy in diagnosis of weaning induced pulmonary oedema
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 1, 2020

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

July 1, 2021

Study Registration Dates

First Submitted

July 5, 2020

First Submitted That Met QC Criteria

July 8, 2020

First Posted (Actual)

July 9, 2020

Study Record Updates

Last Update Posted (Actual)

July 9, 2020

Last Update Submitted That Met QC Criteria

July 8, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • LULTRASOUND

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on lung ultrasound

Subscribe